CODX vs MAS
Co-Diagnostics, Inc. Common Stock (CODX) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
CODX currently screens at market cap $31.4M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the CODX and MAS stock pages for the full models.
Not investment advice.